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Online Resource 1. SPM12 analysis of [18F]UCB-H PVE-corrected Vt maps: Peak MNI 
coordinates of brain regions showing significant reduction in synaptic density in mild AD 
patients (n = 14) compared to controls  
Regions Cluster 
size 
x y z  Z score 
Right anterior hippocampus* 218 14 -8 -18  4.02 
Right superior temporal** 55 62 -16 42  4.32 
Right middle frontal* 50 34 50 30  4.01 
* p <0.10 FWE-corrected at the voxel-level; ** p <0.05 FWE-corrected at the voxel-level. PVE, 





Online Resource 2. [18F]UCB-H mean values from PVE-corrected Vt maps in ROIs as a 
function of group (mild AD only versus controls) 
ROI Mild AD Controls  % diff Effect 
size (d) 
Hippocampus 3.8 (0.7) 5.4 (1.4) t(31)=3.6, p<0.001 -29.0 1.29 
Basal forebrain Ch1-3 1.5 (0.8) 2.3 (1.5) t(31)=1.9, p=0.05 -37.7 0.69 
Basal forebrain Ch4 4.5 (1.1) 5.1 (1.3) t(31)=1.4, p=0.15 -12.3 0.49 
Parahippocampal 4.8 (0.9) 5.6 (1.2) t(31)=2.1, p<0.05 -14.6 0.72 
Thalamus 4.5 (0.9) 5.4 (1.2) t(31)=2.1, p<0.05 -15.7 0.74 
Parietal 4.0 (0.9) 4.9 (1.2) t(31)=2.2, p<0.05 -18.3 0.77 
Posterior cingulate 4.7 (1.2) 5.3 (1.2) t(31)=1.3, p=0.18 -10.8 0.45 
Prefrontal 4.3 (0.8) 5.0 (1.1) t(31)=2.0, p=0.05 -14.2 0.69 
Temporal 4.7 (1.0) 5.5 (1.2) t(31)=2.0, p<0.05 -15.2 0.70 
Occipital 3.7 (1.2) 4.5 (1.1) t(31)=1.9, p=0.06 -17.7 0.65 
      
“Control” regions      
Centrum semiovale 3.7 (0.8) 3.9 (0.9) t(31)=0.6, p=0.55 -4.7 0.20 
Cerebellum 3.7 (0.8) 4.0 (0.9) t(31)=1.2, p=0.23 -9.2 0.40 
Note: Standard deviations in parentheses. ROI, region of interest. % diff = (mean AD – mean 
controls)/mean controls x 100%. PVE, partial volume effect; Vt, distribution volume; ROI, 




Online Resource 3. [18F]UCB-H mean values from non-PVE-corrected Vt maps in ROIs as a 




Controls  % diff Effect 
size (d) 
Hippocampus 4.4 (1.0) 5.4 (1.3) t(41)=2.7, p<0.01 -17.8 0.80 
Basal forebrain Ch1-3 2.9 (1.0) 3.9 (1.1) t(41)=2.8, p<0.01 -23.7 0.82 
Basal forebrain Ch4 4.9 (0.9) 5.5 (1.4) t(41)=1.8, p=0.06 -12.1 0.54 
Parahippocampal 4.6 (1.1) 5.5 (1.3) t(41)=2.4, p<0.05 -15.9 0.71 
Thalamus 4.5 (1.0) 5.2 (1.2) t(41)=2.1, p<0.05 -13.6 0.61 
Parietal 4.2 (1.3) 4.8 (1.3) t(41)=1.4, p=0.16 -11.2 0.42 
Posterior cingulate 4.6 (0.9) 5.2 (1.3) t(41)=1.9, p=0.05 -12.7 0.57 
Prefrontal 4.2 (1.1) 4.7 (0.9) t(41)=1.4, p=0.16 -9.9 0.42 
Temporal 4.8 (1.1) 5.6 (1.3) t(41)=1.9, p=0.05 -13.2 0.58 
Occipital 4.1 (1.2) 4.8 (1.2) t(41)=1.9, p=0.05 -15.1 0.58 
      
“Control” regions      
Centrum semiovale 3.8 (0.8) 4.0 (0.9) t(41)=0.9, p=0.36 -5.8 0.26 
Cerebellum 4.0 (0.9) 4.5 (1.1) t(41)=1.5, p=0.14 -9.9 0.44 
Note: Standard deviations in parentheses. ROI, region of interest. % diff = (mean AD – mean 
controls)/mean controls x 100%. PVE, partial volume effect; Vt, distribution volume; ROI, 





Online Resource 4: Correlation between [18F]UCB-H uptake and grey matter density in the 
hippocampus in the AD group. Left: PVE-corrected PET images, correlation: r = 0.78, p < 
0.001; right= PET images without any PVE-correction, correlation: r = 0.44, p < 0.05. 
 
 
